For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03833154
D9103C00001: A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Unresected Stage I/II, Lymph-node negative No
Contact Name:
Kathryn Tower
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Kruti Patel, MD
IRB number :
1422369
Study Number:
RTOG3515/D1903C00001
Phone:
Fax:
EA2182, A Randomized Phase II Study of De-intensified Chemoradiation for Early Stage Anal Squamous Cell Carcinoma (DECREASE)
Contact Name:
Steven Schmitt
Study Type:
Oncology - Gastrointestinal
Study Status:
Open to Accrual
Principal investigator:
Geoffrey Neuner, MD
IRB number :
1722503
Study Number:
EA2182
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04166318
EA3132: Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing
Contact Name:
Steven Schmitt
Study Type:
Oncology - Head and Neck
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
1342138
Study Number:
EA3132
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT02501954
EA3161: A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Contact Name:
Steven Schmitt
Study Type:
Oncology - Head and Neck
Study Status:
Suspended
Principal investigator:
Mei Tang, MD
IRB number :
1483311
Study Number:
EA3161
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03811015
EA3202: Testing the Use of Investigational Drugs Atezolizumab and/​or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
Contact Name:
Study Type:
Oncology - Head and Neck
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
2167690
Study Number:
EA3202
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05063552